SchiaffinoLab

Cancer and Aging, Healthcare Delivery Systems Science, Population Health and Context, Complex Systems @ucsd

[SchiaffinoLab @SchiaffinoLab]

This is a little exciting :)

[Dr Rishabh Jain @DrRishabhOnco]

🫁 THE 10 MOST IMPORTANT LUNG CANCER TRIALS OF #ASCO26

🎯 TARGETED THERAPY MOVES EARLIER

1️⃣ LIBRETTO-432 (LBA3)
Adjuvant selpercatinib in resected RET+ NSCLC
Precision medicine officially enters curative-intent RET disease.

2️⃣ NeoADAURA
Neoadjuvant osimertinib ± chemotherapy in EGFR-mutant NSCLC
Targeted therapy keeps moving earlier.

3️⃣ CROWN 7-Year Update
Lorlatinib vs crizotinib in ALK+ NSCLC
Are we finally seeing a true survival plateau?

4️⃣ MARIPOSA Updated OS
Amivantamab + lazertinib vs osimertinib
The efficacy vs toxicity debate continues.

5️⃣ Beamion LUNG-1 CNS Cohort
Zongertinib in HER2-mutant NSCLC
Critical intracranial activity data.

🧬 FRONTLINE PRECISION EXPANSION

6️⃣ SUNVOZERTINIB 1L
Frontline uncommon EGFR-mutant NSCLC
A huge unmet-need population.

7️⃣ Olomorasib 1L Cohort
Second-generation KRAS G12C inhibition moves upfront
KRAS continues evolving rapidly.

🔥 IMMUNOLOGY & BISPECIFICS

8️⃣ HARMONi-6 (LBA4)
Ivonescimab + chemo vs tislelizumab + chemo
PD-1/VEGF bispecifics enter frontline squamous NSCLC.

9️⃣ DeLLphi-312
Tarlatamab in 1L ES-SCLC
Potentially practice-changing if positive.

🔟 IMforte Subtype Analysis
Can molecular SCLC subtypes finally guide maintenance therapy?

Which thoracic abstract are you watching most closely? 👀

#LungCancer #LCSM #OncTwitter #MedTwitter #ASCO26 @ASCO @IASLC @myesmo @esmo_open @OncoAlert

[SchiaffinoLab @SchiaffinoLab]

We want to hear from our Bilingual SDSU students with experience in healthcare or related fields. Your contribution to our project will make an impact for future Bilingual Research Assistants! #MakeADifference #SDSU #Healthcare #Research #Bilingual #PublicHealth

[SchiaffinoLab @SchiaffinoLab]

We are looking for participants for our study! Please see below to see if you are eligible or if anyone you know may be eligible. #Bilingual #PublicHealth #SDSU #UCSD #Research

[RCMAR VI National Coordinating Center @RCMARCC]

RCMAR Workshop at GSA on Pragmatic Clinical Trials on Nov 2: Learn about the implementation of trials, with representative patient populations, and outcome measures including those living with Alzheimer’s disease and Alzheimer’s disease related dementias. https://t.co/2TslbPJSki

[Melody Schiaffino (she/ella) @DrSchiaffino]

I’ve not been posting as much but I think it’s because we are doing so much and pushing so many great projects forward @SchiaffinoLab I’m so proud of my students #luckyPI @SDSUResearch #LegacySpeakersProject

[Melody Schiaffino (she/ella) @DrSchiaffino]

@KBibbinsDomingo (far left) joined the @ImSatUCSF #RISE2022 #COMB9 and #10 cohorts to talk about her new role as @JAMA_current EiC and reunite with us!!! We ❤️ you!

[SDSU School of Public Health @sdsuhealth]

Congratulations to Dr. Schiaffino, who was promoted to Associate Professor with tenure within the Health Management and Policy division! @SchiaffinoLab
Read more about her background and research here: https://t.co/d0dB93o3QY

[SchiaffinoLab @SchiaffinoLab]

@SchiaffinoLab PI presenting with @mycarg panel at #ASCO22 @mexicolindo @SDSUResearch on the importance of including diverse, vulnerable, and Limited English Proficient older adults in research to ensure equity in cancer care delivery

[Melody Schiaffino (she/ella) @DrSchiaffino]

Love!!!

[Idalid "Ivy" Franco MD MPH @IvyRadOncMD]

Highlight of #ASCO22 was meeting @mexicolindo!

Follow her on Twitter & really wanted to meet in person. Wasn’t sure she’d reply. Sent message anyway.

Glad I did! Connected on so many levels! Agradecida por mi nueva amiga! 🇲🇽💪🏽💜 @LatinxOncology @LatinasInMed #HSR #HealthEquity

[Melody Schiaffino (she/ella) @DrSchiaffino]

Excellent explanation of AI underlying assumptions that we take for granted

[Melody Schiaffino (she/ella) @DrSchiaffino]

Also nice to have a friendly and familiar hat in the audience, boy was I nervous!! @SchumacherPhD so happy to work with you on this and looking forward to keep going! @SDSUResearch @UCSDHealthCHEER @UCSDGeriatrics @SchiaffinoLab #ASCO22

[Melody Schiaffino (she/ella) @DrSchiaffino]

Check out the manuscript on “Why Older Adults Belong” w/ more in depth discussion of the framework discussed at #ASCO22 panel on the accumulated barriers that diverse older adults face when they access health services! @SchiaffinoLab @SDSUResearch

[Melody Schiaffino (she/ella) @DrSchiaffino]

Here is the link to the manuscript from our amazing #ASCO22 panel "Social Justice and Equity: Why Older Adults With Cancer Belong—A Life Course Perspective" @SDSUResearch @SchiaffinoLab @sdsuhealth @UCSDGeriatrics @UCSDCancer https://t.co/BYXAlKMkoB

[Jeremy Howard @jeremyphoward]

This is amazing - an in-browser sign language (ASL) recogniser built with @fastdotai, @PyTorch, and @unity.
https://t.co/jC6bENNe1X

[Melody Schiaffino (she/ella) @DrSchiaffino]

@SchiaffinoLab

[SchiaffinoLab @SchiaffinoLab]

I’m on a 3 day streak learning German on Duolingo! Join me? https:^//invite.duolingo.com/BDHTZTB5CWWKS6CQIZOMSJ7QFI?v=sm&g=tw

[Kirk Borne @KirkDBorne]

9 Best Free Online Courses for #Statistics for #DataScience in 2022 — compiled by @tut_ml
————
#BigData #DataScientists #DataLiteracy #StatisticalLiteracy #MachineLearning #Mathematics
https://t.co/pRDHbITRw2

[Dede K. Teteh-Brooks @DrTeteh]

Dr Jacqueline Kerr, mom, behavior scientist & #burnout survivor shares her story & her solutions in this inspiring TEDx talk with a recipe for system & social change not self-care. Check out https://t.co/aJRZoLZgmY!

[World Health Organization (WHO) @WHO]

#WHA75 starts Sunday. Follow history in the making:
✅ A Director-General will be elected to lead the Organization for the next 5 years
✅ Access to health care; creating healthy environments for all; pandemic preparedness will be discussed
✅ Peace & health is the Assembly theme